National Institute of Allergy and Infectious Diseases (NIAID): all 2,445 studies

Page 2 of 25. Open to participants first (182), then studies with results posted, then the rest; newest registration first within each.

• Metabolic Profiling of Immune Responses in Immune-mediated DiseasesRecruitingNCT04864886
• Observational Digital Biomarker Discovery in Respiratory Virus Challenge StudiesRecruitingNCT04772170
• Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and ConvalescenceRecruitingNCT04582903
• Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)RecruitingNCT04097561Phase 1
• Paradoxical Tuberculosis Reactions in Patients Without HIV InfectionRecruitingNCT04052022
• Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)RecruitingNCT04047628Phase 3
• Febrile Disease Landscape in Cambodia Via Metagenomic Pathogen SequencingRecruitingNCT04034264
• Belimumab With Rituximab for Primary Membranous NephropathyRecruitingNCT03949855Phase 2
• Collection of Human Biospecimens for Basic and Clinical Research Into Globin VariantsRecruitingNCT03937817
• Connors Protocol for the Management and Use of Stored Human Specimens (Stored Human Specimens)Enrolling by invitationNCT03895645
• Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy VolunteersRecruitingNCT03878121Phase 1
• Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic DermatitisRecruitingNCT03835767Phase 2
• Send-In Sample Collection to Achieve Genetic and Immunologic Characterization of Primary ImmunodeficienciesRecruitingNCT03610802
• Sample Collection From Healthy Volunteers for Assay OptimizationRecruitingNCT03538600
• The Mechanistic Biology of Primary Immunodeficiency DisordersRecruitingNCT03394053
• Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates.RecruitingNCT03298334Phase 1/2
• NIAID Centralized Sequencing ProtocolRecruitingNCT03206099
• An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With UstekinumabRecruitingNCT03167437Phase 1/2
• Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)RecruitingNCT03109288Phase 1/2
• Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases)RecruitingNCT02974595
• Type 1 Diabetes Extension StudyRecruitingNCT02734277
• Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria ChallengeRecruitingNCT02639299
• Long-term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza ChallengeEnrolling by invitationNCT02511002
• Natural History and Genetics of Food Allergy and Related ConditionsRecruitingNCT02504853
• Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine CandidatesRecruitingNCT02471378
• Novel Genetic Disorders of the Immune SystemRecruitingNCT02257892
• Pathogenesis and Genetics of Disseminated or Refractory CoccidioidomycosisRecruitingNCT02190266
• Quantitative Measurement and Correlates of the Latent HIV Reservoir in Virally Suppressed UgandansRecruitingNCT02154035
• PET Imaging and Lymph Node Assessment of IRIS in People With AIDSRecruitingNCT02147405
• Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV RemissionRecruitingNCT02140255Phase 1/2
• Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine ModelsRecruitingNCT02015013Phase 2
• Natural History Study of GATA2 Deficiency and Related DisordersRecruitingNCT01905826
• Natural History of Individuals With Immune System Problems That Lead to Fungal InfectionsRecruitingNCT01386437
• Screening for LID Clinical Studies Unit Healthy Volunteer ProtocolsRecruitingNCT01386424
• Screening Volunteers for Clinical TrialsRecruitingNCT01375530
• Viral Infections in Healthy and Immunocompromised HostsRecruitingNCT01306084
• Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)RecruitingNCT01306019Phase 1/2
• Studies of Disorders With Increased Susceptibility to Fungal InfectionsRecruitingNCT01222741
• Training Protocol on the Natural History of TuberculosisRecruitingNCT01212003
• Admission and Management of Occupational or Other Exposures to Biodefense/Bioterrorism Agents or to Epidemic/Emerging Infectious DiseasesRecruitingNCT01200953
• Natural History Study of SCID DisordersEnrolling by invitationNCT01186913
• Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, MaliRecruitingNCT01168271
• VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and OlderRecruitingNCT01132859
• The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known ImmunocompromiseRecruitingNCT01011712
• Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation DisordersEnrolling by invitationNCT00895271
• Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ LymphocytopeniaRecruitingNCT00867269
• Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous SystemRecruitingNCT00794352
• Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV InfectionRecruitingNCT00789009
• Analysis of HIV-1 Replication During Antiretroviral TherapyEnrolling by invitationNCT00767312
• Diagnosis and Management of Inflammatory and Infectious DiseasesRecruitingNCT00557726
• Detection and Characterization of Infections and Infection SusceptibilityRecruitingNCT00404560
• Diagnosis and Treatment of Leishmania InfectionsRecruitingNCT00344188
• Molecular Basis of Human Phagocyte Interactions With Bacterial PathogensRecruitingNCT00339287
• Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell DeathRecruitingNCT00246857
• Evaluation of Patients With Immune Function AbnormalitiesRecruitingNCT00128973
• Apheresis to Obtain Plasma or White Blood Cells for Laboratory StudiesRecruitingNCT00114647
• A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease ProgressionRecruitingNCT00091871
• Collection of Data and Samples From Healthy Donors for Use in Translational ResearchRecruitingNCT00090662
• Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research StudiesRecruitingNCT00067054
• Study of Factors Regulating Mast Cell ProliferationRecruitingNCT00044122
• Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research ParticipantsRecruitingNCT00039689
• Genetic Studies of Chronic Active Epstein-Barr DiseaseRecruitingNCT00032513
• Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressorsRecruitingNCT00029445
• Evaluation, Treatment, and Follow-up of Patients With Lyme DiseaseRecruitingNCT00028080
• Study of Mycobacterial InfectionsRecruitingNCT00018044
• Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)RecruitingNCT00006150
• Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital ToxoplasmosisRecruitingNCT00004317Phase 4
• Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic InfectionRecruitingNCT00001645
• A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control PopulationsRecruitingNCT00001539
• Genetic Analysis of Immune DisordersRecruitingNCT00001467
• Activation and Function of Eosinophils in Conditions With Blood or Tissue EosinophiliaRecruitingNCT00001406
• Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and GranulocytesRecruitingNCT00001405
• Detection and Characterization of Host Defense DefectsRecruitingNCT00001355
• Fungal Infection SusceptibilityRecruitingNCT00001352
• Evaluation and Long-Term Follow-up of Patients With Inflammatory DisordersEnrolling by invitationNCT00001351
• Study of Autoimmune Lymphoproliferative Syndrome (ALPS)RecruitingNCT00001350
• Viral Load in Blood and Lymph Tissues in People Living With HIVRecruitingNCT00001316
• Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIVRecruitingNCT00001281
• Immune Regulation in Patients With Common Variable Immunodeficiency and Related Inborn Errors of Immunity (IEI)RecruitingNCT00001244
• Host Response to Infection and Treatment in Filarial DiseasesRecruitingNCT00001230
• Natural History of Treated Neurocysticercosis and Long-Term OutcomesRecruitingNCT00001205
• Immune Regulation in Ulcerative Colitis or Crohn s DiseaseRecruitingNCT00001184
• Phase 1 Study on Bioavailability, Food Effect, and Drug-Drug Interaction of ALG-097558 Tablets in Healthy VolunteersCompletedNCT06945276Phase 1Results posted
• Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)CompletedNCT06729606Phase 3Results posted
• Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)CompletedNCT06729593Phase 3Results posted
• Study of the Infectivity, Safety and Immunogenicity of Two Recombinant, Live-Attenuated, B/HPIV3 Vectored Vaccines Expressing the Fusion Glycoprotein of HMPV Delivered by Nasal Spray to HPIV3-Seropositive Children 24 to <60 Months of AgeCompletedNCT06546423Phase 1Results posted
• L9LS MAb in Malian InfantsCompletedNCT06461026Phase 1Results posted
• Phase 1, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of an Enterovirus D68-specific Monoclonal Antibody in Healthy AdultsCompletedNCT06444048Phase 1Results posted
• Safety Study of SLV213 for the Treatment of COVID-19.TerminatedNCT06146374Phase 1Results posted
• Estradiol Therapy In Transgender Women to Research Interactions With HIV TherapyTerminatedNCT06005610Phase 2Results posted
• Effect of Bismuth Subsalicylate on the Gut Microbiome and Host Response in Healthy AdultsCompletedNCT05930197Phase 1Results posted
• A Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding a Native-like HIV Env Trimer and Interleukin-12 (INO-6160), Alone or in a Prime-boost Regimen With 3M-052-AF + Alum Adjuvanted VRC HIV Env Trimer 4571 in Adult Participants Without HIVCompletedNCT05828095Phase 1Results posted
• L9LS MAb in Malian AdultsCompletedNCT05816330Phase 2Results posted
• Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding NP-GT8 and IL-12, With or Without a TLR-agonist-Adjuvanted HIV Env Trimer 4571 Boost, in Adults Without HIVCompletedNCT05781542Phase 1Results posted
• PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)TerminatedNCT05780541Phase 3Results posted
• MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)CompletedNCT05780463Phase 3Results posted
• AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)CompletedNCT05780437Phase 3Results posted
• BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)CompletedNCT05780424Phase 3Results posted
• VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)CompletedNCT05780281Phase 3Results posted
• LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)CompletedNCT05780268Phase 3Results posted

← National Institute of Allergy and Infectious Diseases (NIAID) overview and focus areas